Search Results - "Rodrigo Daza Arnedo"

Refine Results
  1. 1

    Prediabetes and CKD: Does a causal relationship exist by Rico Fontalvo, Jorge, Soler, María José, Daza Arnedo, Rodrigo, Navarro-Blackaller, Guillermo, Medina-González, Ramón, Rodríguez Yánez, Tomas, Cardona-Blanco, Maria, Cabrales-Juan, Jose, Uparrela-Gulfo, Isabella, Chávez-Iñiguez, Jonathan S.

    Published in Nefrología (01-09-2024)
    “…The relationship between diabetes and the development of kidney complications is well known, but the understanding of prediabetes and insulin resistance with…”
    Get full text
    Journal Article
  2. 2

    Molecular Mechanisms of Diabetic Kidney Disease by Rico-Fontalvo, Jorge, Aroca, Gustavo, Cabrales, Jose, Daza-Arnedo, Rodrigo, Yánez-Rodríguez, Tomas, Martínez-Ávila, María Cristina, Uparella-Gulfo, Isabella, Raad-Sarabia, María

    “…The inflammatory component of diabetic kidney disease has become of great interest in recent years, with genetic and epigenetic variants playing a fundamental…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Novel Biomarkers of Diabetic Kidney Disease by Rico-Fontalvo, Jorge, Aroca-Martínez, Gustavo, Daza-Arnedo, Rodrigo, Cabrales, José, Rodríguez-Yanez, Tomás, Cardona-Blanco, María, Montejo-Hernández, Juan, Rodelo Barrios, Dairo, Patiño-Patiño, Jhonny, Osorio Rodríguez, Elber

    Published in Biomolecules (Basel, Switzerland) (31-03-2023)
    “…Diabetic kidney disease (DKD) is a highly prevalent condition worldwide. It represents one of the most common complications arising from diabetes mellitus (DM)…”
    Get full text
    Journal Article
  7. 7

    Additional Considerations in the Treatment of Diabetic Nephropathy Based on the KDOQI Clinical Practice Guideline by Rico Fontalvo, Jorge, Montejo Hernández, Juan David, Daza Arnedo, Rodrigo, Cabrales, Jose

    “…Obesity is a risk factor for the development and progression of CKD, which has been shown in numerous studies. The mechanism of how this occurs is not…”
    Get full text
    Journal Article
  8. 8

    Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits by Rico-Fontalvo, Jorge, Daza-Arnedo, Rodrigo, Cabrales Juan, Jose Rafael, Montejo-Hernández, Juan Diego

    “…We have read the article published by Kadowaki, et al. 1 “Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Severe hypoglycemia: Is it important to take into account the albuminuria value? by Rico-Fontalvo, Jorge, Daza-Arnedo, Rodrigo, Bohorquez-Rivero, Jose, Restom-Arrieta, Jose

    “…The authors conclude that in patients with DM2, more advanced CKD was associated with greater insulin use, proposing different explanations of this…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Uso de dapagliflozina en pacientes con nefropatía por IgA: reporte de una serie de cinco casos by Rico-Fontalvo, Jorge, Daza-Arnedo, Rodrigo, Montejo-Hernández, Juan Diego, Romero-Martínez, Geraldine, Romero-Martínez, Shairine, Rodríguez-Yánez, Tomás

    “…Introducción: los inhibidores del cotransportador sodio-glucosa tipo 2 (iSGLT2) son terapias innovadoras que han mostrado beneficios más allá del control…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Plasmaféresis en síndrome Hellp: reporte de un caso y revisión de la literatura by Borre Naranjo, Diana, Saavedra Valencia, Laura, Vergara Schotborgh, Alejandra, Lavalle López, Oscar, Aguilar Schotborgh, Miguel Ángel, Daza Arnedo, Rodrigo

    Published in Revista ciencias biomédicas (07-03-2022)
    “…Introducción: el síndrome HELLP históricamente se ha considerado una complicación grave de la preeclampsia, cuyo tratamiento consiste en la estabilización…”
    Get full text
    Journal Article